Searched for: school:SOM
Department/Unit:Child and Adolescent Psychiatry
Attention-deficit/hyperactivity disorder (ADHD): from randomised controlled trials to evidence-based clinical services
Cortese, S; Barbui, C
PMID: 28065196
ISSN: 2045-7960
CID: 2415572
Becoming mindful: Integrating mindfulness into your psychiatric practice [Meeting Abstract]
Desai, S; Schlechter, A; Kurahashi, M; Hedrick, R; Zoogman, S
Objectives: The application of mindfulness-based practices in psychiatry is indeed real and patient-level outcomes include symptom reduction and enhanced sense of well-being. Perhaps as importantly, the provider also experiences gains such as enhanced attention, empathy, compassion, and resilience. Methods: This hands-on workshop led by experienced mindfulness-based researchers, practitioners, and authors will consider the evidence for mindfulness in clinical psychiatry and teach the audience several simple mindfulness exercises for themselves and their patients. Results: Upon workshop completion, participants will have considered the application of mindfulness in several common practice-based cases in child psychiatry. Conclusions: The clinician will be able to define mindfulness, understand its applications, refine mindfulness techniques as part of their toolkit, and access mindfulness resources for themselves and their child and adolescent patients
EMBASE:620079557
ISSN: 1527-5418
CID: 2924312
Sleep education and hygiene [Meeting Abstract]
Shatkin, J P
Objectives: This presentation will provide participants with an understanding of standard sleep hygiene recommendations and their utility, along with other less commonly addressed interventions, to promote a good night's sleep. At the end of this presentation, participants will be able to 1) describe the evidence base for typical sleep hygiene recommendations; 2) identify the effects of exercise, napping, caffeine, alcohol, tobacco, and marijuana on sleep; and 3) determine which sleep hygiene practices are likely to be most effective for children and adolescents. Methods: This presentation will draw upon a comprehensive literature review, the physiology of sleep, and case-based material. Results: Sleep hygiene is ubiquitously recommended by psychiatrists, psychologists, and healthcare providers for the treatment of insomnia. However, many commonly suggested techniques are not founded upon convincing research and have not been proven effective in trials. In addition, there are other methods based on findings from sleep physiology studies that may be effective and worth using with children and adolescents who struggle with sleep. This presentation will describe the current knowledge base and deficit in sleep hygiene and then make sensible, evidence-based recommendations for improving sleep in children and adolescents. Common behavioral and exogenous factors, such as exercise, napping, caffeine, alcohol, and tobacco, and their effects on sleep will also be addressed. Conclusions: Understanding the physiology and circadian rhythmicity of sleep is key to understanding and applying sleep hygiene effectively. This presentation will summarize the core components of sleep hygiene that are likely to be of use for children and adolescents
EMBASE:620081526
ISSN: 1527-5418
CID: 2924192
Human Amygdala Tracks a Feature-Based Valence Signal Embedded within the Facial Expression of Surprise
Kim, M Justin; Mattek, Alison M; Bennett, Randi H; Solomon, Kimberly M; Shin, Jin; Whalen, Paul J
Human amygdala function has been traditionally associated with processing the affective valence (negative vs positive) of an emotionally charged event, especially those that signal fear or threat. However, this account of human amygdala function can be explained by alternative views, which posit that the amygdala might be tuned to either (1) general emotional arousal (activation vs deactivation) or (2) specific emotion categories (fear vs happy). Delineating the pure effects of valence independent of arousal or emotion category is a challenging task, given that these variables naturally covary under many circumstances. To circumvent this issue and test the sensitivity of the human amygdala to valence values specifically, we measured the dimension of valence within the single facial expression category of surprise. Given the inherent valence ambiguity of this category, we show that surprised expression exemplars are attributed valence and arousal values that are uniquely and naturally uncorrelated. We then present fMRI data from both sexes, showing that the amygdala tracks these consensus valence values. Finally, we provide evidence that these valence values are linked to specific visual features of the mouth region, isolating the signal by which the amygdala detects this valence information.SIGNIFICANCE STATEMENT There is an open question as to whether human amygdala function tracks the valence value of cues in the environment, as opposed to either a more general emotional arousal value or a more specific emotion category distinction. Here, we demonstrate the utility of surprised facial expressions because exemplars within this emotion category take on valence values spanning the dimension of bipolar valence (positive to negative) at a consistent level of emotional arousal. Functional neuroimaging data showed that amygdala responses tracked the valence of surprised facial expressions, unconfounded by arousal. Furthermore, a machine learning classifier identified particular visual features of the mouth region that predicted this valence effect, isolating the specific visual signal that might be driving this neural valence response.
PMCID:5618267
PMID: 28874449
ISSN: 1529-2401
CID: 4070012
Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: protocol for a systematic review and meta-analysis
Ruiz-Goikoetxea, Maite; Cortese, Samuele; Aznarez-Sanado, Maite; Magallon, Sara; Luis, Elkin O; Zallo, Noelia Alvarez; Castro-Manglano, Pilar de; Soutullo, Cesar; Arrondo, Gonzalo
INTRODUCTION: Attention-deficit hyperactivity disorder (ADHD) has been related to increased rates of unintentional injuries. However, the magnitude of the effect and to which extent variables such as sex, age or comorbidity can influence this relationship is unknown. Additionally, and importantly, it is unclear if, and to which degree, ADHD medications can decrease the number of unintentional injuries. Due to the amount of economic and social resources invested in the treatment of injuries, filling these gaps in the literature is highly relevant from a public health standpoint. Here, we present a protocol for a systematic review and meta-analysis to estimate the relationship between ADHD and unintentional injuries and assess the impact of pharmacological treatment for ADHD METHODS AND ANALYSIS: We will combine results from 114 bibliographic databases for studies relating ADHD and risk of injuries. Bibliographic searches and data extraction will be carried out independently by two researchers. The studies' risk of bias will be assessed using the Newcastle-Ottawa Scale. Articles reporting ORs or HRs of suffering an injury in ADHD compared with controls (or enough data to calculate them) will be combined using Robust Variance Estimation, a method that permits to include multiple non-independent outcomes in the analysis. All analyses will be carried out in Stata. Age, sex and comorbid conduct disorders will be considered as potential causes of variance and their effect analysed through meta-regression and subgroup analysis. Sensitivity analyses will exclude articles with longer follow-ups, non-stringent definitions of ADHD or controls and statistically uncontrolled/controlled outcomes. Studies implementing a self-controlled case series methodology to investigate if ADHD drugs reduce the risk of injuries will be combined with a generalised linear mixed model using the Poisson distribution and a log link function. REGISTRATION DETAILS: PROSPERO-Prospective Register of Systematic Reviews (CRD42017064967).
PMCID:5623547
PMID: 28951416
ISSN: 2044-6055
CID: 2717632
Risperidone-Induced Amenorrhea in Floridly Psychotic Female [Case Report]
Shagufta, Shanila; Farooq, Faiza; Khan, Ali M; Dar, Kamil; Mohit, Abdul
Despite the high prevalence of hyperprolactinemia in patients receiving antipsychotic medications, its side effects are often neglected. In patients receiving risperidone, the incidence of menstrual abnormalities is relatively small. Our patient was a 44-year-old, Haitian female whose total course of hospitalization was nine months, during most of which she remained floridly psychotic with low cognitive function with waxing and waning symptoms. She developed hyperprolactinemia and amenorrhea on risperidone. She was treated and discharged to the state mental hospital. Menstrual abnormalities cause psychological distress in women. In women, hyperprolactinemia can cause sexual and reproductive dysfunction. Chronic hyperprolactinemia can predispose to osteoporosis and cardiovascular disease. Clinicians should be vigilant about the consequences when prescribing medications for women, particularly those suffering from a psychotic disorder.
PMCID:5679759
PMID: 29152440
ISSN: 2168-8184
CID: 4969222
Erratum to: Attention training for infants at familial risk of ADHD (INTERSTAARS): study protocol for a randomised controlled trial [Correction]
Goodwin, Amy; Salomone, Simona; Bolton, Patrick; Charman, Tony; Jones, Emily J H; Mason, Luke; Pickles, Andrew; Robinson, Emily; Smith, Tim; Sonuga-Barke, Edmund J S; Wass, Sam; Johnson, Mark H
PMCID:5592716
PMID: 28889798
ISSN: 1745-6215
CID: 3071162
Association Between Linear Growth and Bone Accrual in a Diverse Cohort of Children and Adolescents
McCormack, Shana E; Cousminer, Diana L; Chesi, Alessandra; Mitchell, Jonathan A; Roy, Sani M; Kalkwarf, Heidi J; Lappe, Joan M; Gilsanz, Vicente; Oberfield, Sharon E; Shepherd, John A; Winer, Karen K; Kelly, Andrea; Grant, Struan F A; Zemel, Babette S
Importance:Prevention of osteoporosis in adulthood begins with optimizing bone health in early life. The longitudinal association between growth and bone accretion during childhood is not fully understood. Objectives:To assess the acquisition of whole-body (WB) and skeletal site-specific bone mineral content (BMC) relative to linear growth in a healthy, diverse, longitudinal cohort of children, adolescents, and young adults and to test for differences related to sex and African American race. Design, Setting, and Participants:This investigation was a mixed longitudinal study with annual assessments for up to 7 years at 5 US clinical centers. Participants were healthy children, adolescents, and young adults. The study dates were July 2002 through March 2010. The dates of the analysis were June through December 2016. Main Outcomes and Measures:Anthropometrics, BMC, and body composition via dual-energy x-ray absorptiometry. The superimposition by translation and rotation (SITAR) analysis method was used to define the mean trajectories for height, WB lean soft tissue, appendicular lean soft tissue, and WB and skeletal site-specific BMC acquisition and to measure the age and magnitude of peak velocity for each parameter. The SITAR modeling was performed separately by sex and self-reported race. Results:Among 2014 healthy children, adolescents, and young adults (1022 [50.7%] female and 479 [23.8%] African American) aged 5 to 19 years at study entry, the mean age of peak height velocity was 13.1 years (95% CI, 13.0-13.2 years) in African American boys vs 13.4 years (95% CI, 13.3-13.4 years) in non-African American boys (difference, -0.3 years; 95% CI, -0.4 to -0.1 years) and 11.0 years (95% CI, 10.8-11.1 years) in African American girls vs 11.6 years (95% CI, 11.5-11.6 years) in non-African American girls (difference, -0.6 years; 95% CI, -0.7 to -0.5 years). Age of peak acquisition of WB BMC was 14.0 years (95% CI, 13.8-14.1 years) in African American boys vs 14.0 years (95% CI, 13.9-14.1 years) in non-African American boys (difference, -0.0 years; 95% CI, -0.2 to 0.2 years) and 12.1 years (95% CI, 12.0-12.3 years) in African American girls vs 12.4 years (95% CI, 12.3-12.5 years) in non-African American girls (difference, -0.3 years; 95% CI, -0.4 to -0.1 years). At age 7 years, children had acquired 69.5% to 74.5% of maximal observed height but only 29.6% to 38.1% of maximal observed WB BMC. Adolescents gained 32.7% to 35.8% of maximal observed WB BMC during the 2 years before and 2 years after peak height velocity. Another 6.9% to 10.7% of maximal observed WB BMC occurred after linear growth had ceased. In the group at highest risk for fracture, non-African American boys, peak fracture incidence occurred approximately 1 year before peak height velocity. Conclusions and Relevance:In this longitudinal study, height gains substantially outpaced gains in BMC during childhood, which could contribute to fracture risk. A significant proportion of bone is accrued after adult height is achieved. Therefore, late adolescence represents a potentially underrecognized window of opportunity to optimize bone mass.
PMCID:5632753
PMID: 28672287
ISSN: 2168-6211
CID: 3985462
Assessment of the impact of shared data on the scientific literature [PrePrint]
Milham, Michael P; Craddock, R Cameron; Fleischmann, Michael; Son, Jake; Clucas, Jon; Xu, Helen; Koo, Bonhwang; Krishnakumar, Anirudh; Biswal, Bharat B; Castellanos, FX; Colcombe, Stan; Di Martino, Adriana; Zuo, Xi-Nian; Klein, Arno
ORIGINAL:0014348
ISSN: 2692-8205
CID: 4151792
Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress
Swift, Thomas C; Belser, Alexander B; Agin-Liebes, Gabrielle; Devenot, Nese; Terrana, Sara; Friedman, Harris L; Guss, Jeffrey; Bossis, Anthony P; Ross, Stephen
Recent randomized controlled trials of psilocybin-assisted psychotherapy for patients with cancer suggest that this treatment results in large-magnitude reductions in anxiety and depression as well as improvements in attitudes toward disease progression and death, quality of life, and spirituality. To better understand these findings, we sought to identify psychological mechanisms of action using qualitative methods to study patient experiences in psilocybin-assisted psychotherapy. Semistructured interviews were conducted with 13 adult participants with clinically elevated anxiety associated with a cancer diagnosis who received a single dose of psilocybin under close clinical supervision. Transcribed interviews were analyzed using interpretative phenomenological analysis, which resulted in 10 themes, focused specifically on cancer, death and dying, and healing narratives. Participants spoke to the anxiety and trauma related to cancer, and perceived lack of available emotional support. Participants described the immersive and distressing effects of the psilocybin session, which led to reconciliations with death, an acknowledgment of cancer's place in life, and emotional uncoupling from cancer. Participants made spiritual or religious interpretations of their experience, and the psilocybin therapy helped facilitate a felt reconnection to life, a reclaiming of presence, and greater confidence in the face of cancer recurrence. Implications for theory and clinical treatment are discussed.
ISI:000407511800004
ISSN: 1552-650x
CID: 2676992